Exclusive: Obesity biotech Verdiva hires ex-Metsera CMO as crucial readouts near

Verdiva Bio names ex-Metsera CMO Steve Marso as its new medical chief ahead of interim EVOLVE-2 data on its oral GLP-1 pill ecnoglutide.

Raccontata daendpoints.news